Skip to content

Research at St Andrews

Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

Research output: Contribution to journalArticlepeer-review

Author(s)

M. Flook, C. Jackson, E. Vasileiou, C.R. Simpson, M.D. Muckian, Utkarsh Agrawal, Colin McCowan, Y. Jia, J.L.K. Murray, L.D. Ritchie, C. Robertson, S.J. Stock, X. Wang, M.E.J. Woolhouse, A. Sheikh, H.R. Stagg

School/Research organisations

Abstract

Background

Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) has challenged public health agencies globally. In order to effectively target government responses, it is critical to identify the individuals most at risk of coronavirus disease-19 (COVID-19), developing severe clinical signs, and mortality. We undertook a systematic review of the literature to present the current status of scientific knowledge in these areas and describe the need for unified global approaches, moving forwards, as well as lessons learnt for future pandemics.

Methods

Medline, Embase and Global Health were searched to the end of April 2020, as well as the Web of Science. Search terms were specific to the SARS-CoV-2 virus and COVID-19. Comparative studies of risk factors from any setting, population group and in any language were included. Titles, abstracts and full texts were screened by two reviewers and extracted in duplicate into a standardised form. Data were extracted on risk factors for COVID-19 disease, severe disease, or death and were narratively and descriptively synthesised.

Results

One thousand two hundred and thirty-eight papers were identified post-deduplication. Thirty-three met our inclusion criteria, of which 26 were from China. Six assessed the risk of contracting the disease, 20 the risk of having severe disease and ten the risk of dying. Age, gender and co-morbidities were commonly assessed as risk factors. The weight of evidence showed increasing age to be associated with severe disease and mortality, and general comorbidities with mortality. Only seven studies presented multivariable analyses and power was generally limited. A wide range of definitions were used for disease severity.

Conclusions

The volume of literature generated in the short time since the appearance of SARS-CoV-2 has been considerable. Many studies have sought to document the risk factors for COVID-19 disease, disease severity and mortality; age was the only risk factor based on robust studies and with a consistent body of evidence. Mechanistic studies are required to understand why age is such an important risk factor. At the start of pandemics, large, standardised, studies that use multivariable analyses are urgently needed so that the populations most at risk can be rapidly protected.

Close

Details

Original languageEnglish
Article number342
Number of pages23
JournalBMC Infectious Diseases
Volume21
DOIs
Publication statusPublished - 12 Apr 2021

    Research areas

  • Coronavirus, COVID-19, Systematic review, Review, Risk factors, Morbidity, Mortality

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Ethnic and social inequalities in COVID-19 outcomes in Scotland: protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)

    Henery, P., Vasileiou, E., Hainey, K. J., Buchanan, D., Harrison, E., Leyland, A., Alexis, T., Robertson, C., Agrawal, U., Ritchie, L., Stock, S., McCowan, C., Docherty, A., Kerr, S., Marple, J., Wood, R., Moore, E., Simpson, C., Shiekh, A. & Katikireddi, S., Aug 2021, In: BMJ Open. 11, 8, 8 p., e048852.

    Research output: Contribution to journalArticlepeer-review

  2. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study

    Simpson, C. R., Robertson, C., Vasileiou, E., Moore, E., McCowan, C., Agrawal, U., Stagg, H. R., Docherty, A., Mulholland, R., Murray, J. LK., Ritchie, L. D., McMenamin, J. & Sheikh, A., 5 Jul 2021, (E-pub ahead of print) In: The Lancet Digital Health. Online First, 9 p.

    Research output: Contribution to journalArticlepeer-review

  3. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

    Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., McCowan, C., Agrawal, U., Shah, S. A., Ritchie, L. D., Murray, J., Pan, J., Bradley, D. T., Stock, S. J., Wood, R., Chuter, A., Beggs, J., Stagg, H. R., Joy, M., Tsang, R. S. M. & 10 others, de Lusignan, S., Hobbs, R., Lyons, R. A., Torabi, F., Bedston, S., O'Leary, M., Akbari, A., McMenamin, J., Robertson, C. & Sheikh, A., 9 Jun 2021, (E-pub ahead of print) In: Nature Medicine. 16 p.

    Research output: Contribution to journalArticlepeer-review

  4. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

    Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., de Lusignan, S., Docherty, A. B., Ford, D., Hobbs, FD. R., Joy, M., Katikireddi, S. V., Marple, J., McCowan, C., McGagh, D., McMenamin, J. & 12 others, Moore, E., Murray, J. LK., Pan, J., Ritchie, L., Shah, S. A., Stock, S., Torabi, F., Tsang, R. SM., Wood, R., Woolhouse, M., Robertson, C. & Sheikh, A., 1 May 2021, In: The Lancet. 397, 10285, p. 1646-1657

    Research output: Contribution to journalArticlepeer-review

  5. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database

    Mulholland, R. H., Vasileiou, E., Simpson, C. R., Robertson, C., Ritchie, L. D., Agrawal, U., Woolhouse, M., Murray, J. L. K., Stagg, H. R., Docherty, A. B., McCowan, C., Wood, R., Stock, S. J. & Sheikh, A., 16 Apr 2021, (E-pub ahead of print) In: International Journal of Epidemiology. Advance Article, 11 p., dyab028.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Crook, A. M., Amukoye, E. I., Dawson, R., Diacon, A. H., Hanekom, M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murphy, M. E., Murthy, S. E., Nunn, A. J., Phillips, P. P. J., Singh, K. P., Spigelman, M., Wills, G. H. & Gillespie, S. H., 11 Jul 2018, In: BMC Infectious Diseases. 18, 11 p., 317.

    Research output: Contribution to journalArticlepeer-review

  2. TST positivity in household contacts of tuberculosis patients: a case-contact study in Malawi

    Hector, J., Anderson, S. T., Banda, G., Kamdolozi, M., Jefferys, L. F., Shani, D., Garton, N. J., Mwale, A., Jobe, A., Davies, G. R. & Sloan, D. J., 11 Apr 2017, In: BMC Infectious Diseases. 17, 7 p., 259.

    Research output: Contribution to journalArticlepeer-review

  3. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum

    Drevinek, P., Holden, M. T. G., Ge, Z., Jones, A. M., Ketchell, I., Gill, R. T. & Mahenthiralingam, E., 19 Sep 2008, In: BMC Infectious Diseases. 8, 16 p., 121.

    Research output: Contribution to journalArticlepeer-review

ID: 273373160

Top